{"transactions":[{"id":792321,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-05T20:42:04.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":152783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option (the \"Option\") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the \"Plan\"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan)."}],"balance_after":152783,"derivative":{"exercise_price":0.841,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":152783},"source":{"system":"sec-edgar","filing":"0001213900-26-052261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390026052261/ownership.xml","form_type":"4"}},{"id":985368,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T14:07:14.000Z","date":"2025-11-28","kind":"purchase","planned":false,"acquired":true,"shares":133333,"price":0.75,"value":99999.75,"ownership":{"direct":true},"balance_after":199691,"source":{"system":"sec-edgar","filing":"0001213900-25-116309","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390025116309/ownership.xml","form_type":"4"}},{"id":1013346,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-27T21:27:18.000Z","date":"2025-10-24","kind":"grant","planned":false,"acquired":true,"shares":242913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option (the \"Option\") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the \"Plan\"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan)."}],"balance_after":242913,"derivative":{"exercise_price":0.715,"expiration_date":"2035-10-23","underlying":"Common Stock","underlying_shares":242913},"source":{"system":"sec-edgar","filing":"0001213900-25-102682","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390025102682/ownership.xml","form_type":"4"}},{"id":1099526,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-30T21:34:53.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained."}],"balance_after":110000,"derivative":{"exercise_price":0.929,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001213900-25-059798","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390025059798/ownership.xml","form_type":"4/A","original_submission_date":"2025-06-20"}},{"id":1099525,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-30T21:34:53.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":44959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan (the \"Equity Plan\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer."}],"balance_after":112493,"source":{"system":"sec-edgar","filing":"0001213900-25-059798","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390025059798/ownership.xml","form_type":"4/A","original_submission_date":"2025-06-20"}},{"id":1105311,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-20T20:45:02.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 1/2 on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2025 Option Incentive Plan. The 2025 Option Incentive Plan is subject to stockholder approval and (i) no options can be exercised prior to obtaining stockholder approval for such plan, and (ii) the outstanding options will be cancelled, if stockholder approval is not obtained."}],"balance_after":110000,"derivative":{"exercise_price":0.929,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001213900-25-056269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390025056269/ownership.xml","form_type":"4"}},{"id":1105310,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:45:02.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":48198,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of December 17, 2025 and June 17, 2026, subject to the recipient's continued service to the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer."}],"balance_after":115732,"source":{"system":"sec-edgar","filing":"0001213900-25-056269","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390025056269/ownership.xml","form_type":"4"}},{"id":1106719,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-18T23:44:03.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 18, 2026,  or (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date."}],"balance_after":78459,"source":{"system":"sec-edgar","filing":"0000950170-25-088063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000095017025088063/ownership.xml","form_type":"4"}},{"id":1253575,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-21T23:24:29.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock shares subject to time-based vesting, which vest at the rate of 1/2 of such shares on each of July 1, 2025 and December 31, 2025, subject to the recipient's continued service to the Issuer. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors of the Issuer. Issued under the Issuer's 2022 Equity Compensation Plan."}],"balance_after":67534,"source":{"system":"sec-edgar","filing":"0001213900-25-016193","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390025016193/ownership.xml","form_type":"4"}},{"id":1479536,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T20:15:11.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU will vest as to 100% of the total number of shares on the earlier of (i) June 13, 2025, and (ii) the next Company annual meeting of stockholders, subject to the reporting person's continued service through the vesting date."}],"balance_after":54959,"source":{"system":"sec-edgar","filing":"0000950170-24-073675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000095017024073675/ownership.xml","form_type":"4"}},{"id":1547030,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-06T01:45:10.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), on March 1, 2024, was $8.13 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option award (the \"Option\") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":8.13,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-24-030957","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390024030957/ownership.xml","form_type":"4/A","original_submission_date":"2024-03-01"}},{"id":1607772,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T02:47:15.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award (the \"Option\") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":8.34,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-24-019222","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390024019222/ownership.xml","form_type":"4"}},{"id":1705359,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-20T01:24:44.000Z","date":"2023-12-19","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.0524,"value":41048.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The range of prices for the shares of Common Stock is from $2.005 to $2.07. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price."}],"balance_after":38459,"source":{"system":"sec-edgar","filing":"0001209191-23-059284","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919123059284/doc4.xml","form_type":"4"}},{"id":1787624,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-09-06T22:55:41.000Z","date":"2023-09-04","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Granted in consideration for services rendered and to be rendered as a member of the Board of Directors for the quarter ended June 30, 2023. Granted under the registrant's First Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates."}],"balance_after":15000,"derivative":{"exercise_price":0.67,"expiration_date":"2033-09-04","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-23-074493","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390023074493/ownership.xml","form_type":"4"}},{"id":1854743,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T22:40:07.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 14, 2024 or (b) the day before the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":3.55,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-037546","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919123037546/doc4.xml","form_type":"4"}},{"id":1865500,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-07T01:00:08.000Z","date":"2023-06-02","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.431,"value":12930.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.38 to $0.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":1327174,"source":{"system":"sec-edgar","filing":"0001493152-23-020333","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000149315223020333/ownership.xml","form_type":"4"}},{"id":1870525,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T12:00:18.000Z","date":"2023-06-01","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":1.226,"value":22068.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.15 to $1.26. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.15 to $1.26. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":48129,"source":{"system":"sec-edgar","filing":"0001213900-23-045386","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390023045386/ownership.xml","form_type":"4"}},{"id":2103557,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-28T21:00:26.000Z","date":"2022-11-28","kind":"grant","acquired":true,"shares":5000,"price":0.98,"value":4900.0,"ownership":{"direct":true},"balance_after":1287174,"source":{"system":"sec-edgar","filing":"0001213900-22-075491","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022075491/ownership.xml","form_type":"4"}},{"id":2107289,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-22T21:10:19.000Z","date":"2022-11-22","kind":"grant","acquired":true,"shares":5000,"price":0.99,"value":4950.0,"ownership":{"direct":true},"balance_after":1282174,"source":{"system":"sec-edgar","filing":"0001213900-22-074585","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022074585/ownership.xml","form_type":"4"}},{"id":2131811,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-26T21:35:52.000Z","date":"2022-10-26","kind":"grant","acquired":true,"shares":5000,"price":1.1,"value":5500.0,"ownership":{"direct":true},"balance_after":1277174,"source":{"system":"sec-edgar","filing":"0001213900-22-066554","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022066554/ownership.xml","form_type":"4"}},{"id":2136460,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-17T22:11:13.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":9000,"price":1.13,"value":10170.0,"ownership":{"direct":true},"balance_after":1272174,"source":{"system":"sec-edgar","filing":"0001213900-22-064401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022064401/ownership.xml","form_type":"4"}},{"id":2136459,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-17T22:11:13.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":1000,"price":1.14,"value":1140.0,"ownership":{"direct":true},"balance_after":1263174,"source":{"system":"sec-edgar","filing":"0001213900-22-064401","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022064401/ownership.xml","form_type":"4"}},{"id":2218818,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-30T20:15:56.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":5000,"price":1,"value":5000.0,"ownership":{"direct":true},"balance_after":1272174,"source":{"system":"sec-edgar","filing":"0001213900-22-036296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022036296/ownership.xml","form_type":"4"}},{"id":2218817,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-30T20:15:56.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":5000,"price":1.02,"value":5100.0,"ownership":{"direct":true},"balance_after":1267174,"source":{"system":"sec-edgar","filing":"0001213900-22-036296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022036296/ownership.xml","form_type":"4"}},{"id":2221413,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-27T20:15:11.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":5000,"price":1,"value":5000.0,"ownership":{"direct":true},"balance_after":1262174,"source":{"system":"sec-edgar","filing":"0001213900-22-035201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022035201/ownership.xml","form_type":"4"}},{"id":2223199,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-23T20:31:12.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":5000,"price":1,"value":5000.0,"ownership":{"direct":true},"balance_after":1257174,"source":{"system":"sec-edgar","filing":"0001213900-22-034621","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022034621/ownership.xml","form_type":"4"}},{"id":2224430,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (to acquire common stock)","published_at":"2022-06-22T20:30:46.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted 100,000 stock options. The stock options have a ten-year term and vest over two years, subject to reporting person remaining employed and in good standing, one-half vesting on the first anniversary of the grant date, and the remainder vesting on the second anniversary of the grant date."}],"balance_after":100000,"derivative":{"exercise_price":6,"exercise_date":"2022-08-02","expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001213900-22-034366","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022034366/ownership.xml","form_type":"4"}},{"id":2224429,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-22T20:30:46.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":652174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of the Issuer issued in connection with the acquisition of the ALPHA-5 Integrin, LLC on June 21, 2022."}],"balance_after":1252174,"source":{"system":"sec-edgar","filing":"0001213900-22-034366","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390022034366/ownership.xml","form_type":"4"}},{"id":2228436,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T23:53:13.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 16, 2023 or (b) the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":2.48,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-22-038172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919122038172/doc4.xml","form_type":"4"}},{"id":2477595,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-10T13:22:39.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3."}],"balance_after":25000,"derivative":{"exercise_price":3.95,"exercise_date":"2021-12-08","expiration_date":"2031-12-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-21-064570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390021064570/ownership.xml","form_type":"4"}},{"id":2477594,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-10T13:22:39.000Z","date":"2021-12-09","kind":"purchase","acquired":true,"shares":5000,"price":4.27,"value":21350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $4.24 to $4.28. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":602574,"source":{"system":"sec-edgar","filing":"0001213900-21-064570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390021064570/ownership.xml","form_type":"4"}},{"id":2526958,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-03T21:09:39.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":450,"price":30,"value":13500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended."}],"balance_after":18459,"source":{"system":"sec-edgar","filing":"0001209191-21-062747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919121062747/doc4.xml","form_type":"4"}},{"id":2549677,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T12:16:21.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":5216,"price":6,"value":31296.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 30, 2021, the Issuer entered into a Debt Conversion Agreement with the Reporting Person, pursuant to which the parties agreed to convert an aggregate of $31,297 owed by the Registrant to the Reporting Person, for advances previously made to the Registrant's subsidiaries, into an aggregate of 5,216 shares of common stock of the Issuer. Exempt from Section 16(b) pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The agreed upon conversion price of the conversion of the debt described in Footnote (1) above was the greater of the closing consolidated bid price or the market price on the date the conversion agreement was entered into, and $6.00 per share, provided that because $6.00 was above the closing consolidated bid price and the market price, the conversion price was fixed at $6.00 per share."}],"balance_after":597574,"source":{"system":"sec-edgar","filing":"0001013762-21-000203","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000101376221000203/ownership.xml","form_type":"4"}},{"id":2566375,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-17T18:05:42.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":450,"price":36.82,"value":16569.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended."}],"balance_after":18909,"source":{"system":"sec-edgar","filing":"0001209191-21-056574","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919121056574/doc4.xml","form_type":"4"}},{"id":2598317,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-18T21:48:35.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":450,"price":40.6,"value":18270.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended."}],"balance_after":19359,"source":{"system":"sec-edgar","filing":"0001209191-21-052295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919121052295/doc4.xml","form_type":"4"}},{"id":2630824,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T01:25:26.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":450,"price":38.29,"value":17230.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale effected under sales plan pursuant to Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended."}],"balance_after":19809,"source":{"system":"sec-edgar","filing":"0001209191-21-047324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919121047324/doc4.xml","form_type":"4"}},{"id":2666708,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T01:27:44.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":12307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 15, 2022 or (b) the next annual meeting of stockholders, subject to the Optionee continuing to provide services to the Company through the vesting date; provided however, that if the Optionee ceases to provide services to the Company prior to the vesting date for any reason other than Cause (as defined in the Plan), such Option will vest on a pro-rata basis determined by multiplying the total number of shares by a fraction, the numerator of which is the number of whole months that the Optionee provided services to the Company since the date that the award was granted, and the denominator of which is 12 months."}],"balance_after":12307,"derivative":{"exercise_price":39.64,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":12307},"source":{"system":"sec-edgar","filing":"0001209191-21-041216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919121041216/doc4.xml","form_type":"4"}},{"id":2666707,"issuer":{"id":879,"kind":"organization","name":"BioAtla, Inc.","symbol":"BCAB"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T01:27:44.000Z","date":"2021-06-14","kind":"other","acquired":true,"shares":5388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration."}],"balance_after":20259,"source":{"system":"sec-edgar","filing":"0001209191-21-041216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919121041216/doc4.xml","form_type":"4"}},{"id":2753231,"issuer":{"id":7020,"kind":"organization","name":"FORUM MARKETS Inc"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-08T12:00:55.000Z","date":"2021-04-07","kind":"grant","acquired":true,"shares":22585,"price":6.14,"value":138671.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued in consideration for accrued compensation due for services rendered as Co-Executive Chairman of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Issued in consideration for accrued compensation due for services rendered as Co-Executive Chairman of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3."}],"balance_after":592358,"source":{"system":"sec-edgar","filing":"0001213900-21-020733","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000121390021020733/ownership.xml","form_type":"4"}},{"id":3480329,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-06-24T20:51:31.000Z","date":"2019-06-24","kind":"exercise","acquired":false,"shares":8405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":8405},"source":{"system":"sec-edgar","filing":"0001209191-19-038796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919119038796/doc4.xml","form_type":"4"}},{"id":3480328,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":49724,"kind":"person","name":"STEINMAN LAWRENCE","position":1,"cik":"0001132679","reported_name":"STEINMAN LAWRENCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-24T20:51:31.000Z","date":"2019-06-24","kind":"exercise","acquired":true,"shares":8405,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date."}],"balance_after":258405,"source":{"system":"sec-edgar","filing":"0001209191-19-038796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1132679/000120919119038796/doc4.xml","form_type":"4"}}]}